Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 300 Records) |
| Query Trace: Disease and ALK[original query] |
|---|
| A detailed histological and molecular assessment of the diffuse sclerosing variant of papillary thyroid carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100329. Angela Chou, Min Ru Qiu, Henry Crayton, Bin Wang, Mahsa S Ahadi, John Turchini, Adele Clarkson, Loretta Sioson, Amy Sheen, Nisha Singh, Roderick J Clifton-Bligh, Bruce G Robinson, Matti L Gild, Venessa Tsang, David Leong, Stanley B Sidhu, Mark Sywak, Leigh Delbridge, Ahmad Aniss, Dale Wright, Nicole Graf, Amit Kumar, Vivek Rathi, Paul Benitez-Aguirre, Anthony R Glover, Anthony J Gi |
| Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
| Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report. Case reports in oncology 2023 11 16 (1): 1384-1389. Andrew Davis, Sophia Jarrar, Christine Ciun |
| Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma. The Journal of thoracic and cardiovascular surgery 2024 9 . Hang Cao, Wangyang Zhu, Huatao Tang, Chaoqiang Deng, Fangqiu Fu, Yuan Li, Yang Zhang, Haiquan Ch |
| Outcomes with non-small cell lung cancer and brain-only metastasis. Heliyon 2024 9 10 (17): e37082. Sabine Schmid, Miguel Garcia, Luna Zhan, Sierra Cheng, Khaleeq Khan, Maisha Chowdhury, Amir Sabouhanian, Joshua Herman, Preet Walia, Evan Strom, M Catherine Brown, Devalben Patel, Wei Xu, Frances A Shepherd, Adrian G Sacher, Natasha B Leighl, Penelope A Bradbury, Geoffrey Liu, David Shul |
| The Effect of Intracranial Control After Intracranial Local Therapy on the Prognosis of Patients with Brain Metastasis of Lung Adenocarcinoma. Cancer management and research 2024 8 16 977-988. Minmin Shen, Qiaojing Lin, Xi Zou, Yufan Wu, Zhihong Lin, Linglong Shao, JinSheng Hong, Jinmei Ch |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107920. Virginia Calvo, Emetis Niazmand, Enric Carcereny, Delvys Rodriguez-Abreu, Manuel Cobo, Rafael López-Castro, María Guirado, Carlos Camps, Ana Laura Ortega, Reyes Bernabé, Bartomeu Massutí, Rosario Garcia-Campelo, Edel Del Barco, José Luis González-Larriba, Joaquim Bosch-Barrera, Marta Martínez, María Torrente, María-Esther Vidal, Mariano Provenc |
| The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients. BMC cancer 2024 8 24 (1): 937. Ma?gorzata Fr?k, Anna Grenda, Pawe? Krawczyk, Barbara Ku?nar-Kami?ska, Pawe? Pazdrowski, Karolina K?dra, Izabela Chmielewska, Janusz Milanows |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| A three-year review of lung cancer patient characteristics in a tertiary hospital. Ghana medical journal 2024 7 57 (3): 167-174. Jane S Afriyie-Mensah, Ernest Kwarteng, John Tetteh, Hafi Gbadamosi, Mary-Ann Dadzie, Yaw Boakye Mensah, Ekow Entsua-Mens |
| Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib. Frontiers in oncology 2024 6 14 1405683. Huixian Zhang, Ziheng Zhang, Ningning Yan, Xingya |
| Associations between Radiomics and Genomics in Non-Small Cell Lung Cancer Utilizing Computed Tomography and Next-Generation Sequencing: An Exploratory Study. Genes 2024 6 15 (6): . Alessandro Ottaiano, Francesca Grassi, Roberto Sirica, Emanuela Genito, Giovanni Ciani, Vittorio Patanè, Riccardo Monti, Maria Paola Belfiore, Fabrizio Urraro, Mariachiara Santorsola, Alfonso Maria Ponsiglione, Marco Montella, Salvatore Cappabianca, Alfonso Reginelli, Mario Sansone, Giovanni Savarese, Roberta Gras |
| Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 6 . Jieqiong Fan, Tao Zha |
| Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT). Clinical lung cancer 2024 5 . Andrew Fantoni, Lydia Warburton, Benjamin Solomon, Marliese Alexander, Meghana Maddula, Lauren Julia Brown, Ines Pires da Silva, Adnan Nagrial, Farah Abu Al-Hial, Malinda Itchins, Nick Pavlakis, Samantha Bowy |
| Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification. Frontiers of medicine 2024 5 . Rui Fu, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Yilong Wu, Wenzhao Zho |
| Ocular findings in patients with histiocytosis and association with clinical and molecular features. The British journal of ophthalmology 2024 5 . Jasmine H Francis, Anne S Reiner, Julia Canestraro, Raajit K Rampal, David H Abramson, Eli L Diamo |
| Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 4 . Ying Fu, Qing Liu, Xiaohan Wang, Liangchao Sun, Xiao Han, Xue Me |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Brief Report: Final overall survival and long-term safety of lorlatinib in patients with ALK-positive non-small cell lung cancer from the pivotal phase 2 study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 11 . Sai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, Alessandra Bearz, Chia-Chi Lin, Rita Chiari, D Ross Camidge, Jessica J Lin, Antonello Abbattista, Francesca Toffalorio, Ross A S |
| Cytomorphological and histomorphological features of lung adenocarcinoma with epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene rearrangement. Oncology letters 2024 11 29 (1): 40. Nikola Gardi?, Aleksandra Lovrenski, Vanesa Sekeruš, Svetlana Kašikovi? Le?i?, Milorad Bijelovi?, Tanja Laki?, Aleksandra Ili?, Bojan Zari?, Sofija Glum |
| Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 11 . Paloma Navarro, Carmen Beato, Juan Francisco Rodriguez-Moreno, Sergio Ruiz-Llorente, Xabier Mielgo, Estela Pineda, Miguel Navarro, Gema Bruixola, Tatiana P Grazioso, Antonio Viudez, Jose Fuster, Esther Nogueron, Maria Dolores Mediano, Carmen Balaña, Carlos Mendez, Rosa María Rodriguez, Sonia Del Barco Berron, Beatriz Gongora, Alberto Carmona-Bayonas, Jesus Garcia-Don |
| Inadequate staging and excessive surveillance imaging: Evaluating the magnitude of benefit of targeted therapies in lung cancer. European journal of cancer (Oxford, England : 1990) 2024 10 212 115058. David J Benjamin, Vinay Pras |
| [Clinical characteristics and prognostic factors of epidermal growth factor receptor-mutated non-small cell lung cancer transformed into small-cell lung cancer after treatment]. Zhonghua yi xue za zhi 2024 10 104 (40): 3751-3756. H Zheng, D Zhao, M Gu, Q H Wang, C H Li, X Li, J Li, N Y Che, Y |
| Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations. Journal of clinical medicine 2024 10 13 (19): . Oliver Illini, Hannah Fabikan, Eva Fischer, Anna Sophie Lang-Stöberl, Dagmar Krenbek, Christa Jarius, Shokoufa Azarnia-Medan, Stefan Gasser, Maximilian Johannes Hochmair, Christoph Weinlinger, Arschang Valipour, Stefan Watz |
| Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study. BMC cancer 2024 1 24 (1): 117. Jing Qian, Zelai He, Ying Wu, Hongwei Li, Qun Zhang, Xianming |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
| RET-AREAL: a multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. Cancer letters 2025 1 217455. Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Lia |
- Page last reviewed:Feb 1, 2024
- Content source: